Blog

Human Longevity Acquires Stem Cell Banking Business Unit from Celgene – GenomeWeb

Human Longevity Acquires Stem Cell Banking Business Unit from Celgene
GenomeWeb
As part of the deal, HLI will receive LifebankUSA's proprietary method for high-yield extraction of placental stem cells — this process yields 60 percent to 70 percent more of CD34+ stem cells, which are critical for bone marrow and cord blood
Human Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing with Strategic Acquisition of Stem PR Newswire (press release)


Human Longevity Acquires LifebankUSA, Biomaterials Business from CelgeneGenetic Engineering & Biotechnology News (blog)

all 3 news articles »

2016-01-28
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.